Sage Therapeutics Announces Second Quarter 2019 Financial Results and Highlights Pipeline and Business Progress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. HOOD
9. MU
10. IBM

Go back to Sage Therapeutics Announces Second Quarter 2019 Financial Results and Highlights Pipeline and Business Progress

SAGE Therapeutics (SAGE) Tops Q2 EPS by 5c

August 6, 2019 6:45 AM EDT

SAGE Therapeutics (NASDAQ: SAGE) reported Q2 EPS of ($3.28), $0.05 better than the analyst estimate of ($3.33).

For earnings history and earnings-related data on SAGE Therapeutics (SAGE) click here.

... More